Brief: Nuvation Bio Announces Proposed Convertible Senior Notes Offering
25/06/2026 12:25
BRIEF-Nuvation Bio Announces Proposed Convertible Senior Notes Offering June 25 (Reuters) - Nuvation Bio Inc NUVB.N:
NUVATION BIO ANNOUNCES PROPOSED CONVERTIBLE SENIOR NOTES OFFERING
NUVATION BIO - TO OFFER $200 MILLION CONVERTIBLE SENIOR NOTES DUE 2032
NUVATION BIO - PROCEEDS TO FUND CAPPED CALLS, REPAY SENIOR LOAN, AND GENERAL CORPORATE PURPOSES
Source text: ID:nPn8G9MH3a
Further company coverage: NUVB.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth